Sign inCreate account

Report workspace tools

NCT04390997COMPLETEDanonymous

Determination of the Levels of Lipocalin-2 and Semaphorin3A in Gingival Crevicular Fluid in Subjects With Different Periodontal Diseases

Sponsor

Source record

Izmir Katip Celebi University

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

Non-surgical Periodontal Treatment

Indication / condition

AI-normalized

Gingivitis

Intervention

Source record

Non-surgical Periodontal Treatment

Source & freshness

Source record

NCT ID

NCT04390997

Original source

ClinicalTrials.gov

Source last updated

Feb 10, 2021

Ingested at

Jun 05, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT04390997

Title

Determination of the Levels of Lipocalin-2 and Semaphorin3A in Gingival Crevicular Fluid in Subjects With Different Periodontal Diseases

Sponsor

Izmir Katip Celebi University

Status

COMPLETED

Phase

NA

Condition raw

Gingivitis, Periodontitis, Periodontal Diseases

Condition normalized

Gingivitis, Periodontitis, Periodontal Diseases

Modality raw

medical device

Modality normalized

medical device

Target raw

Non-surgical Periodontal Treatment

Target normalized

Non-surgical Periodontal Treatment

Interventions

Non-surgical Periodontal Treatment

Public preview

Source record

The aim of this clinical trial is to investigate the concentrations of Lipocalin-2 and Semaphorin 3A levels in gingival crevicular fluid in subjects with different periodontal diseases. At the same time for the periodontitis group; the purpose of this study is to analyze the correlation of these proteins with clinical parameters at the first and third months after the nonsurgical periodontal treatment.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Determination of the Levels of Lipocalin-2 and Semaphorin3A in Gingival Crevicular Fluid in Subjects With Different Periodontal Diseases

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT04390997

Status

COMPLETED

Phase

NA

Sponsor

Izmir Katip Celebi University

Executive brief

Investment-Ready Snapshot

The aim of this clinical trial is to investigate the concentrations of Lipocalin-2 and Semaphorin 3A levels in gingival crevicular fluid in subjects with different periodontal diseases. At the same time for the periodontitis group; the purpose of this study is to analyze the correlation of these proteins with clinical parameters at the first and third months after the nonsurgical periodontal treatment.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedFeb 10, 2021
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT04390997

Indication

Gingivitis

Modality

medical device

Target

Non-surgical Periodontal Treatment

Intervention

Non-surgical Periodontal Treatment

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.